HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Use of bromocriptine in unexplained infertility.

Abstract
In order to determine whether infertility of unexplained aetiology would respond to therapy with bromocriptine, 50 regularly ovulating infertile patients were studied in a double-blind placebo controlled trial. Following an observation cycle in which midluteal urinary oestrogen and pregnanediol excretion and late luteal serum PRL and hCG levels were determined, patients were randomly allocated to treatment with either bromocriptine or placebo for three cycles. Patients who did not conceive were then treated for three cycles with the alternative therapy. Eighteen women (36%) conceived, five during the observation cycle, four during treatment with bromocriptine, four whilst receiving placebo and five during the 12 month follow-up period. The pregnancy rate achieved in patients treated with bromocriptine was thus no better than that for the group as a whole.
AuthorsJ C McBain, R J Pepperell
JournalClinical reproduction and fertility (Clin Reprod Fertil) Vol. 1 Issue 2 Pg. 145-50 (Jun 1982) ISSN: 0725-556X [Print] Australia
PMID6764750 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Chorionic Gonadotropin
  • Bromocriptine
  • Prolactin
Topics
  • Bromocriptine (therapeutic use)
  • Chorionic Gonadotropin (blood)
  • Clinical Trials as Topic
  • Double-Blind Method
  • Female
  • Humans
  • Infertility, Female (drug therapy)
  • Male
  • Prolactin (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: